Prophylactic treatment with plasma-derived C1 inhibitor in idiopathic non-histaminergic angioedema

Pediatric Allergy and Immunology

Volumn 27, Issue 6, 2016, Pages 658-659

  Gravante, Carmela ^a   Carucci, Laura ^a   Bova, Maria ^a   Petraroli, Angelica ^a   Genovese, Arturo ^a   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BETAMETHASONE; CETIRIZINE; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4; PLASMA DERIVED C1 INHIBITOR; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANGIONEUROTIC EDEMA; CASE REPORT; CHILD; DRUG TREATMENT FAILURE; GENETIC SCREENING; HUMAN; IDIOPATHIC EDEMA; IDIOPATHIC NON HISTAMINERGIC ANGIOEDEMA; LETTER; LIMB SWELLING; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; PROPHYLAXIS; SCHOOL CHILD;

EID: 84983243533     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12592     Document Type: Letter

References (9)

1. Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the HereditaryAngioedema International Working Group. Allergy 2014: 69: 602–16.
2. Cugno M, Nussberger J, Cicardi M, Agostoni A. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 2003: 3: 311–7.
3. Dy TB, Rasheed M, Parikh P, Bernstein L. Resolution of an acute attack of idiopathic angioedema with ecallantide. Ann Allergy Asthma Immunol 2013: 111: 224–6.
4. Berry A, Firszt R. Successful treatment of idiopathic angioedema with ecallantide. J Allergy Clin Immunol Pract 2013: 1: 297–8.
5. Mansi M, Zanichelli A, Coerezza A, et al. Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients. J Intern Med 2015: 277: 585–93.
6. Wintenberger C, Boccon-Gibod I, Launay D, et al. Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients. Clin Exp Immunol 2014: 178: 112–7.
7. Du-Thanh A, Raison-Peyron N, Drouet C, Guillot B. Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema. Allergy 2010: 65: 793e795.
8. Stahl MC, Harris CK, Matto S, Bernstein JA. Idiopathic nonhistaminergic angioedema successfully treated with ecallantide, icatibant, and C1 esterase inhibitor replacement. J Allergy Clin Immunol Pract 2014: 2: 818–9.
9. Shroba J, Hanson J, Portnoy J. Current treatment options for idiopathic angioedema. Ann Allergy Asthma Immunol 2015: 115: 429–33.